Glandular carcinomas of the cervix

ESGO eAcademy, Ate van der Zee, 232410

Cancer in pregnancy

ESGO eAcademy, Frederic Amant, 232409

Small cell and neuroendocrine tumours

ESGO eAcademy, Nicholas Reed, 232408

Carcinosarcoma, mucinous tumours, clear cell cancers & high grade serous cancers

ESGO eAcademy, Mansoor Raza Mirza, 232407

Keynote - Pathology of low grade tumours

ESGO eAcademy, Glenn McCluggage, 232394

Keynote - Molecular genetics of rare gynaecological cancers

ESGO eAcademy, David Huntsman, 232390

Quality of life and late treatments effects

ESGO eAcademy, Florence Joly, 232389

National and international registries & epidemiology

ESGO eAcademy, Domenica Lorusso, 232388

Approaches to treatment - organisation and central review

ESGO eAcademy, Mojgan Devouassoux, 232387

ESGO-ESMO Consensus conference on ovarian cancer standard treatment: final recommendations

ESGO eAcademy, Nicoletta Colombo, 232386

Management of non-epithelial ovarian malignancies

ESGO eAcademy, Cristiana Sessa, 219071

Adjuvant treatment in early, advanced and recurrent ovarian cancer

ESGO eAcademy, Mansoor Mirza, 219382

Video: surgical procedures in advanced ovarian cancer

ESGO eAcademy, Christina Fotopoulou, 219070

Surgical management of primary and recurrent ovarian cancer

ESGO eAcademy, Denis Querleu, 219381

Epidemiology and histopathology of ovarian cancer

ESGO eAcademy, Piotr Bernaczyk, 219069

Diagnosis and staging of ovarian cancer

ESGO eAcademy, Anna Fagotti, 219068

Management of surgical complications

ESGO eAcademy, Christina Fotopoulou, 219066

Symptom control and pain management (palliative care)

ESGO eAcademy, Cristiana Sessa, 219065

Perioperative care

ESGO eAcademy, Christina Fotopoulou, 219064

Familial gynecological cancer: risk assessment and management

ESGO eAcademy, Fedro Alessandro Peccatori, 219383

Diagnosis and management of uterine sarcoma

ESGO eAcademy, Michael Halaska, 219063

Fertility preserving options in endometrial cancer

ESGO eAcademy, Pawel Knapp, 219062

Video: laparoscopic paraaortic lymphadenectomy

ESGO eAcademy, Denis Querleu, 219061

Video: open paraaortic lymphadenectomy

ESGO eAcademy, Christina Fotopoulou, 219060

Adjuvant treatment of endometrial cancer

ESGO eAcademy, Mansoor Mirza, 219058

Surgical management of endometrial cancer

ESGO eAcademy, Denis Querleu, 219057

Diagnosis in endometrial cancer

ESGO eAcademy, Pawel Knapp, 219056

Epidemiology and histopathology of hyperplasia and endometrial cancer

ESGO eAcademy, Jaroslaw Swatek, 219055

Video: Partial/radical vulvectomy and groin node dissection, SLNM

ESGO eAcademy, Michael Halaska, 219054

Management of advanced stage and recurrent vulvar cancer

ESGO eAcademy, Mansoor Mirza, 219053

Primary treatment of early stage vulvar cancer

ESGO eAcademy, Kamil Zalewski, 219052

Epidemiology and histopathology

ESGO eAcademy, Piotr Bernaczyk, 219051

Fertility sparing procedures in cervical carcinoma (trachelectomy, NAC)

ESGO eAcademy, Michael Halaska, 219050

Video of radical hysterectomy (including nerve sparing)

ESGO eAcademy, David Cibula, 219049

Management of locally advanced carcinoma

ESGO eAcademy, Robert Jach, 219380

Cervical cancer: management of early invasive carcinoma

ESGO eAcademy, David Cibula, 219379

Ultrasound, MRI, staging in cervical cancer

ESGO eAcademy, Michael Halaska, 219046

Epidemiology and prevention of cervical cancer

ESGO eAcademy, Robert Jach, 219045

Surgical spaces, lymphatic drainage, nerves, topography

ESGO eAcademy, Denis Querleu, 219044

Ureteral reconstruction and Urinary conduits

ESGO eAcademy, Luis M. Chiva, 209153

Bowel surgery 

ESGO eAcademy, David Cibula, 209152

Bowel preparation

ESGO eAcademy, Dimitrios Haidopoulos, 209151

Video Assisted Thoracoscopic Surgery (VATS)

ESGO eAcademy, Murat Gultekin, 209150

Stomach mobilization - resection - placement of J-tube

ESGO eAcademy, Jalid Sehouli, 209149

Dissection of Porta Hepatis, Celiac Trunk and Techniques for Cholecystectomy

ESGO eAcademy, Denis Querleu, 209148

Splenectomy and Distal Pancreatectomy

ESGO eAcademy, David Cibula, 209147

Diaphragm stripping - resection - repair

ESGO eAcademy, Anna Fagotti, 209146

Liver Mobilization & Cardio-Phrenic LND

ESGO eAcademy, Luis M. Chiva, 209145

Morbidity and postoperatieve outcome

ESGO eAcademy, Jalid Sehouli, 209144

Nutrition

ESGO eAcademy, Philippe Morice, 209143

Preoperative and Postoperative evaluation of the advanced ovarian cancer patient

ESGO eAcademy, Stephanie Suria, 209142

Modified posterior exenteration and Excision of the pouch of Douglas sparing the rectum

ESGO eAcademy, Philippe Morice, 209141

Pelvic and Paarotic llymphadenectomy

ESGO eAcademy, Denis Querleu, 209140

Evaluation of the extension of the disease

ESGO eAcademy, Anna Fagotti, 209139

Science of tissue management - energy and hemostats, stapplers, ednocutters

ESGO eAcademy, Dimitrios Haidopoulos, 209138

Surgery in advanced epithelial ovarian cancer - Quality control

ESGO eAcademy, Luis M. Chiva, 211211

The aim of cytoreduction in ovarian cancer surgery

ESGO eAcademy, Murat Gultekin, 209137

CURRENT AND FUTURE DIRECTIONS FOR GRANULOSA CELL TUMOUR MANAGEMENT

ESGO eAcademy, Isabelle Ray-Coquard, 202840

WHAT IS THE STATE-OF-THE-ART FOR OVARIAN GERM CELL TUMOURS?

ESGO eAcademy, Jalid Sehouli, 202839

HEREDITARY GYNAECOLOGICAL CANCERS: PREVENTION AND ROLE OF PROPHYLACTIC SURGERIES

ESGO eAcademy, Ranjit Manchanda, 202843

HOW CAN WE ELIMINATE DEATHS IN HIGH RISK GTN?

ESGO eAcademy, Michael Seckl, 202838

STATE OF ART IN SCREENING OF GYNAECOLOGICAL CANCERS

ESGO eAcademy, Murat Gultekin, 202842

RECENT DEVELOPMENTS IN GTD AND MOLAR PREGNANCIES

ESGO eAcademy, Leon Massuger, 202837

THE IMPACT OF HEALTHY LIFE STYLE AND OBESITY ON PREVENTION OF GYNAECOLOGICAL CANCERS

ESGO eAcademy, Maria Kyrgiou, 202841

LAPAROSCOPIC VERSUS OPEN TREATMENT OF ENDOMETRIAL CANCER IN ELDERLY WOMEN

ESGO eAcademy, Ignacio Zapardiel, 202833

PREDICTIVE MARKERS IN CERVICAL CANCER

ESGO eAcademy, Cornelis D de Kroon, 203136

ELDERLY PATIENTS UNDERGOING SURGERY FOR OVARIAN OR CERVICAL CANCER: PERI-OPERATIVE ASSESSMENT AND SURGICAL CHOICES

ESGO eAcademy, Dina Kurdiani, 202832

PREDICTIVE MARKERS IN OVARIAN CARCINOMA

ESGO eAcademy, Alexandra Leary, 202835

FRAILTY EVALUATION AND MEDICAL TREATMENT OF ELDERLY POPULATION WITH GYNAECOLOGICAL MALIGNANCIES

ESGO eAcademy, Annamaria Ferrero, 202831

PREDICTIVE MARKERS IN ENDOMETRIAL CARCINOMA

ESGO eAcademy, Xavier Matias-Guiu, 202834

SUPPORTIVE CARE FOR WOMEN WITH GYNAECOLOGIC CANCER RECEIVING EXTERNAL BEAM RADIOTHERAPY AND BRACHYTHERAPY

ESGO eAcademy, Alina Sturdza, 202830

SUPPORTIVE CARE IN GYNECOLOGIC CANCER PATIENTS RECEIVING MEDICAL TREATMENT

ESGO eAcademy, Jørn Herrstedt, 202829

PERIOPERATIVE SUPPORTIVE CARE IN GYNECOLOGIC CANCER PATIENTS

ESGO eAcademy, Felix Hilpert, 202828

CERVICAL ADENOCARCINOMA IB1 AFTER RADICAL HYSTERECTOMY, POSITIVE LYMPHNODES - EVALUATION OF PERIAORTIC NODES, ADJUVANT THERAPY, MANAGEMENT OF OVARIES

ESGO eAcademy, Sebastien Gouy, 202824

CASE 3: DISTANT METASTASES, ENDOCRINE THERAPY, CHEMOTHERAPY

ESGO eAcademy, Guenter Emons, 202827

PLATINUM ELIGIBLE RECURRENT OVARIAN CANCER

ESGO eAcademy, Cristiana Sessa, 202820

CERVICAL CANCER IB1, 2CM TUMOR DIAMETER: SLN BIOPSY, MANAGEMENT IN REGARD TO ABSENCE/PRESENCE OF METASTATIC DISEASE

ESGO eAcademy, Alexander W. Reinthaller, 202823

CASE 2: ADVANCED, METASTATIC, TREATMENT WITH RADIOTHERAPY AND CHEMOTHERAPY

ESGO eAcademy, Melanie Powell, 202826

RECURRENT OVARIAN CANCER - ROLE OF SURGERY

ESGO eAcademy, Philipp Harter, 202819

SURGICAL MANAGEMENT IN PRIMARY OVARIAN CANCER

ESGO eAcademy, Giovanni Aletti, 202818

CERVICAL CANCER STAGE IB1, 3CM TUMOR DIAMETER: EVALUATION OF LYMPH NODES, RISK FACTORS AND THERAPEUTIC MANAGEMENT

ESGO eAcademy, Remi Nout, 202822

CASE 1: ADVANCED ENDOMETRIAL CANCER, AMENABLE TO SURGICAL RESECTION, ROLE OF NEOADJUVANT CHEMOTHERAPY

ESGO eAcademy, Frederic Amant, 202825

CURRENT CLINICALLY MEANINGFUL ASPECTS IN HEREDITARY UTERINE CANCER INCLUDING LYNCH SYNDROME

ESGO eAcademy, Uzi Beller, 202814

THE IMMUNOTHERAPY STORY

ESGO eAcademy, Lana Kandalaft, 202817

CURRENT CLINICALLY MEANINGFUL ASPECTS AND IMPORTANCE OF GERMLINE AND SOMATIC MUTATIONS IN HEREDITARY OVARIAN CANCER

ESGO eAcademy, Pauline Wimberger, 202813

THE PARP-I STORY

ESGO eAcademy, Andres Poveda, 202816

CURRENT CLINICALLY MEANINGFUL ASPECTS AND IMPORTANCE OF GERMLINE AND SOMATIC MUTATIONS IN HEREDITARY BREAST CANCER

ESGO eAcademy, Jan Lubinski, 202812

SURGICAL TRAILS

ESGO eAcademy, Andreas Du Bois, 202815

Conservative surgery for the treatment of granulosa cell tumors of the ovary: results from the MITO 9 study

ESGO eAcademy, Alice Bergamini, 202926

A COMPARATIVE STUDY OF TWO FOLLOW-UP STRATEGIES FOLLOWING TREATMENT OF ENDOMETRIAL CANCER BETWEEN AN ITALIAN AND A UK CENTRE

ESGO eAcademy, Valentina Ghirardi, 203531

HOW TO ASSESS RESECTABILITY AT PRIMARY SURGERY?

ESGO eAcademy, Anna Fagotti, 202808

WHICH ROLE CAN PATIENT REPORTED OUTCOMES AND QUALITY OF LIFE HAVE IN CLINICAL TRIALS

ESGO eAcademy, Remi Nout, 202811

Prospective Clinical Cohort Study For Efficacy Assessment Of Topical Treatment With Olivoleina On Post-Surgical Scars In Patients Undergoing Radiotherapy For Gyneacologic Cancers

ESGO eAcademy, Jesus Molero Vilchez, 202925

ANGIOGENESIS

ESGO eAcademy, sandro pignata, 202807

HOW TO INTEGRATE PATIENT REPORTED OUTCOME TOOLS IN THE EVERYDAY GYNAECOLOGICAL CANCER CLINIC

ESGO eAcademy, Galina Velikova, 202810

BRCA/HRD

ESGO eAcademy, Jonathan Ledermann, 202806

OVERVIEW OF CURRENT DEVELOPMENTS IN MEASURING AND REPORTING PATIENT REPORTED OUTCOMES AND QUALITY OF LIFE IN GYNAECOLOGICAL CANCER

ESGO eAcademy, Lonneke van de Poll-Franse, 202809

MANAGEMENT OF RECURRENT DISEASE

ESGO eAcademy, Frederic Amant, 202799

CERVICAL CANCER IMMUNOTHERAPY TRIAL

ESGO eAcademy, Hans Nijman, 202804

CONSERVATIVE TREATMENT OF ENDOMETRIAL CANCER IN YOUNG WOMEN

ESGO eAcademy, Dimitrios Haidopoulos, 202798

OVARIAN CANCER IMMUNOTHERAPY TRIALS

ESGO eAcademy, Jonathan Ledermann, 202803

RADICAL TREATMENT OF ENDOMETRIAL CANCER IN YOUNG WOMEN

ESGO eAcademy, Nicoletta Colombo, 202797

RISK FACTORS AND PATHOGENESIS OF ENDOMETRIAL CANCER IN YOUNG WOMEN

ESGO eAcademy, Vesna Kesic, 202796

PRINCIPLES OF IMMUNOTHERAPY

ESGO eAcademy, Christian Marth, 202801

Prognostic Value Of Lymph Node Ratio And Number Of Positive Inguinal Nodes In Patients With Vulvar Cancer

ESGO eAcademy, Richard Schwameis, 202924

ONCOLOGICAL MANAGEMENT AND PREGNANCY OUTCOMES IN WOMEN DIAGNOSED WITH CANCER DURING PREGNANCY: A 20-YEAR INTERNATIONAL COHORT STUDY OF 1170 PATIENTS

ESGO eAcademy, Frederic Amant, 202790

MECHANISMS OF RESISTANCE IN BRCA MUTATED TUMORS

ESGO eAcademy, Clare Scott, 202793

QUALITY OF LIFE WITH WEEKLY, DOSE-DENSE VERSUS STANDARD CHEMOTHERAPY FOR OVARIAN CANCER IN THE ICON8 STUDY

ESGO eAcademy, Sarah Blagden, 202788

CLINICALLY SIGNIFICANT LONG-TERM MAINTENANCE TREATMENT WITH OLAPARIB IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSED SEROUS OVARIAN CANCER (PSR SOC)

ESGO eAcademy, Charlie Gourley, 202787

CLINICAL DEVELOPMENT OF OTHER NON PARP TARGETED THERAPIES

ESGO eAcademy, Cristiana Sessa, 202792

HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR OVARIAN CANCER

ESGO eAcademy, Willemien J. Van Driel, 202786

ARIEL3: PHASE 3, RANDOMISED, DOUBLE-BLIND STUDY OF RUCAPARIB VS PLACEBO FOLLOWING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR RECURRENT OVARIAN CARCINOMA (OC)

ESGO eAcademy, Jonathan Ledermann, 202785

UPDATE ON THE CLINICAL DEVELOPMENT OF PARP INHIBITORS

ESGO eAcademy, Iain McNeish, 202791

CLINICAL TRIALS IN PLATINUM-RESISTANT DISEASE

ESGO eAcademy, Mansoor Mirza, 202781

Vulvar Cancer In Ireland: Analysis Of The Irish National Cancer Registry Over A 20 Year Period

ESGO eAcademy, Ann Rowan, 203117

STRATEGIES FOR OVERCOMING RESISTANCE TO CHEMOTHERAPY

ESGO eAcademy, sandro pignata, 202780

PLATINUM-RESISTANT DISEASE: CURRENT STATUS

ESGO eAcademy, Nicole Concin, 202779

RANKL -BONES, SEX, AND BREAST CANCER

ESGO eAcademy, Josef Penninger, 202794

WHY ARE WE FAILING TO CURE OVARIAN CANCER?"

ESGO eAcademy, Christian Marth, 202795

GENERAL IMPLEMENTATION OF IGABT (TRAINING/ MEANS/HEALTH ECONOMICS/RESOURCE LIMITATIONS)

ESGO eAcademy, Christine Haie-Meder, 202775

WHEN, WHY AND HOW TO TEST MISMATCH REPAIR DEFICIENCY IN ENDOMETRIAL CANCER

ESGO eAcademy, Tjalling Bosse, 202778

IMAGE-GUIDED ADAPTIVE BRACHYTHERAPY VERSUS IMRT/STEREOTACTIC RADIOTHERAPY

ESGO eAcademy, Akila Viswanathan, 202774

WHEN, WHY AND HOW TO TEST FOR L1CAM AND P53 EXPRESSION IN ENDOMETRIAL CANCER

ESGO eAcademy, Alain G. Zeimet, 202777

CURRENT STATUS OF IMAGE-GUIDED BRACHYTHERAPY : ONCOLOGICAL RESULTS AND COMPLICATIONS

ESGO eAcademy, Jacob Lindegaard, 202773

WHEN, WHY AND HOW TO TEST POLE MUTATIONAL STATUS IN ENDOMETRIAL CANCER

ESGO eAcademy, David Church, 202776

Interval Between  Cytoreductive Surgery And Adjuvant Chemotherapy Is Associated With Overall Survival In  Patients With Advanced Ovarian Cancer

ESGO eAcademy, Maite Timmermans, 202923

Outcomes Of Robotic Radical Hysterectomy For Cervical Cancer In Comparison To Laparotomy ; A Population Based Study In The United States

ESGO eAcademy, Sabrina Piedimonte, 202922

TREATMENT OF ADVANCED DISEASE, INCLUDING MANAGEMENT OF MORBIDITY

ESGO eAcademy, Alexandra Taylor, 202769

IMPACT OF VAGINAL MORBIDITY ON SEXUALITY AFTER DEFINITIVE RADIOCHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PATIENTS

ESGO eAcademy, Kathrin Kirchheiner, 202772

ADJUVANT TREATMENT

ESGO eAcademy, Carien Creutzberg, 202768

PHYSICAL CONSEQUENCES OF GYNAECOLOGIC CANCER SURGERY AND THEIR IMPACT ON SEXUAL HEALTH

ESGO eAcademy, Michal Zikan, 202771

DIAGNOSTIC AND SURGICAL MANAGEMENT

ESGO eAcademy, Philippe Morice, 202767

SEXUAL HEALTH IN GYNAECOLOGIC CANCER PATIENTS - PSYCHO-SOCIAL CONSEQUENCES OF DIAGNOSIS AND TREATMENT

ESGO eAcademy, Moniek M ter Kuile, 202770

Cervical Cancer Relapse Rates In Patients With Para-Aortic Negitive PET Scans:A Five-Year Analysis In An Irish Gynaeoncology Centre

ESGO eAcademy, Ann Rowan, 202921

Discussion and Closing

ESGO eAcademy, sandro pignata, 202898

Patterns Of Lymph Node Metastases In Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.

ESGO eAcademy, Lucas Minig, 202920

Future therapies

ESGO eAcademy, Kathleen Moore, 202897

Adjuvant management

ESGO eAcademy, Nicoletta Colombo, 202896

Long-Term Efficacy And Immunogenicity Of The 9-Valent Human Papillomavirus Vaccine: Final Analyses Of A Double-Blind, Randomized Clinical Study

ESGO eAcademy, Elmar A. Joura, 202919

Primary debulking strategy

ESGO eAcademy, Sven Mahner, 202895

Front-line Ovarian Cancer: Can we do better?: Welcome and introduction

ESGO eAcademy, sandro pignata, 202766

Mucinous Ovarian Cancer (MOC): What Is The Reproducibility Of The WHO Classification?

ESGO eAcademy, Mojgan Devouassoux, 202918

Refinement Of High-Risk Endometrial-Cancer (HR-EC) Classification Using DNA Damage Response (DDR) Biomarkers: A Transportec Initiative

ESGO eAcademy, Aurélie AUGUSTE, 202917

PERIOPERATIVE CARE OF THE ELDERLY PATIENT

ESGO eAcademy, Karl Tamussino, 202765

MANAGEMENT OF ADVANCED STAGES AND RECURRENT DISEASE

ESGO eAcademy, Richard Poetter, 202761

Adverse Events After Hyperthermic Intraperitoneal Chemotherapy (HIPEC) For Stage III Ovarian Cancer: Phase III OVHIPEC Study

ESGO eAcademy, Simone Koole, 202916

MANAGEMENT OF EARLY STAGES

ESGO eAcademy, David Cibula, 202760

Perioperative Positioning Management In Gynecologic Cancer Surgery: A National NOGGO-AGO Intergroup Survey

ESGO eAcademy, Jenny Katharina Wagner, 202915

WHAT´S NEW IN ANESTHESIA FOR HIGH-RISK PATIENTS: WHAT SURGEONS NEED TO KNOW

ESGO eAcademy, Stephanie Suria, 202763

PATHOLOGY REPORT   

ESGO eAcademy, Maria Rosaria Raspollini, 202759

SHAPING NEW CLINICAL PRACTICE GUIDELINES

ESGO eAcademy, David Cibula, 202758

INITIATING ENHANCED RECOVERY: CHALLENGES AND OPPORTUNITIES

ESGO eAcademy, Lena Wijk, 202762

Hormonal And Fertility Outcome After Fertility Sparing Surgery And Chemotherapy For Ovarian Neoplasms: A Retrospective Study

ESGO eAcademy, Lorenzo Ceppi, 202914

MRI-Based Predictive Factors Of Axillary Lymph Node Metastases In Breast Cancer

ESGO eAcademy, David Atallah, 202913

Experience In Introducing Sentinel Lymph Node Biopsy In Early- Stage Vulva Cancer: A Single Institution Based Prospective Study

ESGO eAcademy, Ligita Paskeviciute Frøding, 202912

ESGO – A STORY OF SUCCESS

ESGO eAcademy, David Cibula, 202757

INTRODUCTION

ESGO eAcademy, Luis M. Chiva, 202756

SUMMARY AND CONCLUSIONS

ESGO eAcademy, Gabriele Calaminus, 202755

TREATMENT OF RECURRENT AND METASTATIC DISEASE

ESGO eAcademy, Ate van der Zee, 202749

CASE PRESENTATION 2 :SERTOLI LEYDIG CELL TUMOR

ESGO eAcademy, Cristiana Sessa, 202754

CASE PRESENTATION 2 :SERTOLI LEYDIG CELL TUMOR

ESGO eAcademy, Dominik Schneider, 202753

CASE PRESENTATION 1 :STAGE I GRADE 3 IMMATURE TERATOMA

ESGO eAcademy, Philippe Morice, 202752

CASE PRESENTATION 1 :STAGE I GRADE 3 IMMATURE TERATOMA

ESGO eAcademy, Gabriele Calaminus, 202751

DIAGNOSIS, STAGING AND PREOPERATIVE WORKUP

ESGO eAcademy, Maaike Oonk, 202747

Practical experiences from CTCA at Southeastern RegionalMedical Center, Georgia USA

ESGO eAcademy, Mansoor Raza Mirza, 202740

Pathological aspects of uterine carcinocarcoma

ESGO eAcademy, Mojgan Devouassoux, 202903

Practical experiences from Klinik für Gynäkologie, Die Charité – Universitätsmedizin Berlin, Germany

ESGO eAcademy, Jacek Grabowski, 202739

CONCLUSION

ESGO eAcademy, Andreas Du Bois, 202736

Q&A and Discussion

ESGO eAcademy, Session Speakers, 203120

SELECTING PATIENTS FOR PARP INHIBITION

ESGO eAcademy, Mansoor Mirza, 202735

RELAPSED OVARIAN CANCER: WHAT DOES MAINTENANCE THERAPY OFFER?

ESGO eAcademy, Nicoletta Colombo, 202733

Welcome and introduction

ESGO eAcademy, Christian Marth, 202732

QUESTIONS REMAINED TO BE ANSWERED

ESGO eAcademy, David Cibula, 202728

CIRCULATING TUMOR CELLS: CHALLENGES & PERSPECTIVES IN GYNAECOLOGICAL CANCERS

ESGO eAcademy, Catherine Alix-Panabieres, 202731

SLN IMPLEMENTATION INTO MANAGEMENT ALGORITHMS

ESGO eAcademy, Nadeem Abu Rustum, 202727

DETECTION OF METHYLATED DNA IN VARIOUS BODY FLUIDS AND THEIR USE AS DIAGNOSTIC, PROGNOSTIC AND PREDICTIVE TOOLS IN GYNAECOLOGICAL CANCERS

ESGO eAcademy, Heidi Fiegl, 202730

WHOLE-GENOME SEQUENCING OF CELL-FREE DNA IN GYNAECOLOGICAL CANCERS

ESGO eAcademy, Adriaan Vanderstichele, 202729

Ultrasound Characteristics Of Endometrial Cancer As Defined By The International Endometrial Tumor Analysis (IETA) Consensus Nomenclature- A Prospective Multicenter Study

ESGO eAcademy, Daniela Fischerova, 202910

LION – LYMPHADENECTOMY IN OVARIAN NEOPLASMS. A PROSPECTIVE RANDOMIZED AGO STUDY GROUP LED GYNECOLOGIC CANCER INTERGROUP TRIAL.

ESGO eAcademy, Domenica Lorusso, 202722

UTERINE CORPUS

ESGO eAcademy, Sigurd Lax, 202725

WHAT MODIFIES THE OUTCOME OF RECURRENT GRANULOSA CELL TUMORS OF THE OVARY?

ESGO eAcademy, Isabel Carriles, 202721

OVARY AND FALLOPIAN TUBE

ESGO eAcademy, Xavier Matias-Guiu, 202724

PRE-SURGICAL METFORMIN IN UTERINE MALIGNANCY-RESULTS OF THE PREMIUM RANDOMISED CONTROLLED TRIAL

ESGO eAcademy, Sarah Kitson, 202719

CERVIX, VULVA, VAGINA

ESGO eAcademy, Glenn McCluggage, 202723

Development And Pre-Testing Of The Eortc Quality Of Life Questionnaire For Vulva Cancer Patients – The Significance Of Patient Involvement

ESGO eAcademy, Pernille Jensen, 202909

Closing and remarks

ESGO eAcademy, Andreas Du Bois, 202716

Being Practical Case 3

ESGO eAcademy, Christian Marth, 202715

Being Practical Case 2

ESGO eAcademy, Nicoletta Colombo, 202714

Being Practical Case 1

ESGO eAcademy, Isabelle Ray-Coquard, 202713

SETTING THE SCENE: QUALITY OF LIFE IN OVARIAN CANCER, IS IT A KEY FACTOR FOR OUR DECISION MAKING?

ESGO eAcademy, Felix Hilpert, 202712

Introduction

ESGO eAcademy, Andreas Du Bois, 202711

Prognostic Factors For Local Recurrence Of Squamous Cell Carcinoma Of The Vulva: A Systematic Review

ESGO eAcademy, Nienke Te Grootenhuis, 202908

The New Normal; Sexual Function after Ovarian Cancer for Survivors and Partners Compared to Normdata

ESGO eAcademy, Maria Caroline Vos, 202907

HOW LONG SHOULD HORMONAL TREATMENT BE CONTINUED BEFORE DECIDING FOR HYSTERECTOMY IN THE FERTILITY SPARING MANAGEMENT OF ENDOMETRIAL CANCER?

ESGO eAcademy, Nicoletta Colombo, 202704

VULVA CANCER

ESGO eAcademy, Ate van der Zee, 202709

The Role Of The Peritoneal Cancer Index In Surgery For Advanced Ovarian Cancer

ESGO eAcademy, Mikkel Rosendahl, 202906

FERTILITY SPARING MANAGEMENT IN CERVICAL CANCERS BETWEEN 2 AND 4 CM: RADICAL TRACHELECTOMY BY LAPAROTOMY OR NEO-ADJUVANT CHEMOTHERAPY?

ESGO eAcademy, Ignance Vergote, 202703

OVARIAN CANCER

ESGO eAcademy, Christoph Grimm, 202708

The Peritoneal Cancer Index(PCI): Selted Regions - And Not The Total PCI - Are Predictive Of Survival In Advanced Ovarian Cancer

ESGO eAcademy, Mikkel Rosendahl, 202905

CAN WE SAFELY USE OVARIAN HYPERSTIMULATION IN INFERTILE PATIENTS AFTER FSS FOR EPITHELIAL TUMORS?

ESGO eAcademy, Dominik Denschlag, 202702

CERVICAL CANCER

ESGO eAcademy, Daniela Fischerova, 202707

FERTILITY SPARING MANAGEMENT IN HIGH RISK EPITHELIAL OVARIAN CANCER

ESGO eAcademy, Enrica Bentivegna, 202701

Imaging in the diagnosis and management of endometrial cancer

ESGO eAcademy, Ingfrid Haldorsen, 202706

CHANGES IN NEOANGIOGENETIC PROFILE OF PAIRED PRIMARY AND RECURRENT HIGH-GRADE SEROUS OVARIAN CANCER (HGOSC): A STUDY OF THE “OCTIPS” CONSORTIUM.

ESGO eAcademy, Ilary Ruscito, 202699

CISPLATIN CHEMO-RADIATION VERSUS RADIATION IN FIGO STAGE IIIB SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX (CRACX TRIAL: NCT00193791)

ESGO eAcademy, Umesh Mahantshetty, 202698

AGO-OVAR 12: A RANDOMIZED PLACEBO-CONTROLLED GCIG/ENGOT-INTERGROUP PHASE III TRIAL WITH CHEMOTHERAPY +/- NINTEDANIB FOR ADVANCED OVARIAN CANCER: OVERALL SURVIVAL RESULTS

ESGO eAcademy, Isabelle Ray-Coquard, 202697

EMBRACE THE MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCER

ESGO eAcademy, Tjalling Bosse, 202696

Randomized Controlled Phase III Study To Evaluate Secondary Cytoreductive Surgery In Platinum-Sensitive Recurrent Ovarian Cancer - AGO Desktop III/ENGOT Ov20

ESGO eAcademy, Jalid Sehouli, 202904

Medical treatment of uterine carcinosarcoma

ESGO eAcademy, Isabelle Ray-Coquard, 190586

Surgical treatment of serous endometrial cancer

ESGO eAcademy, Frederic Guyon, 190585

Surgical treatment of low grade serous ovarian cancer

ESGO eAcademy, Jalid Sehouli, 180471

Medical Tumor Therapy for Germ Cell Tumors of Adults

ESGO eAcademy, Michael Seckl, 180466

Systemic treatment for low grade serous carcinoma

ESGO eAcademy, Michael Seckl, 180469

Surgical treatment for malignant germ cell tumor.

ESGO eAcademy, Pauline Wimberger, 180467

Pathologic aspects of Germ Cell Tumors

ESGO eAcademy, Doris Mayr, 180468

Pathologic aspects of Low Grade Serous Ovarian Cancer

ESGO eAcademy, Doris Mayr, 180470

Look into the future: Medical treatment of ovarian cancer in 2026

ESGO eAcademy, Ignance Vergote, 173572

Immunotherapy in gynecological malignancies

ESGO eAcademy, An Coosemans, 173570

Why do studies of targeted treatment fail?

ESGO eAcademy, Jonathan Ledermann, 173568

Targeting PARP: Mechanisms of action, available evidence, selection of patients, management of toxicities

ESGO eAcademy, Jonathan Ledermann, 173567

Targeting tyrosine kinases

ESGO eAcademy, Jonathan Ledermann, 173566

Molecular pathways in cervical cancer

ESGO eAcademy, Heidi Lyng, 173565

Molecular pathways in endometrial cancer

ESGO eAcademy, Henrica Maria Johanna Werner, 173564

Molecular pathways of low-grade ovarian cancer

ESGO eAcademy, Kristina Lindemann, 173563

Molecular pathways of high grade ovarian cancer

ESGO eAcademy, Adriaan Vanderstichele, 173562

Surgical aspects of uterine carcinosarcoma (~ serous)

ESGO eAcademy, Frederic Amant, 173558

Uterine carcinosarcoma: radiotherapy

ESGO eAcademy, Carien Creutzberg, 173556

Serous endometrial cancer: radiotherapy

ESGO eAcademy, Carien Creutzberg, 173557

Serous endometrial cancer: current management and targeted therapies

ESGO eAcademy, Annamaria Ferrero, 173555

Adjuvant Treatment and Place of Radiation Therapy in Vulvar Cancer

ESGO eAcademy, Carien Creutzberg, 150846

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

ESGO eAcademy, Mansoor Raza Mirza, 154789

New ESGO Guidelines of Management of Vulvar Cancer

ESGO eAcademy, Ate van der Zee, 150845

How to Stage Locally Advanced Cervical Cancer (Radiological and Surgical) before Chemoradiation Therapy

ESGO eAcademy, Sebastien Gouy, 150844

Management of the Clear Cell Ovarian Carcinoma

ESGO eAcademy, Keiichi Fujiwara, 150843

Phase 2: What Information Can We Derive? Rational, Design and Objectives

ESGO eAcademy, Jonathan Ledermann, 150268

Surrogate Endpoints

ESGO eAcademy, Paolo Bruzzi, 150266

Phase 1/1B: What Information Can We Derive? Rational, Design and Objectives

ESGO eAcademy, Cristiana Sessa, 150267

Statistical Plans, Interim Analysis and Subgroup Analysis

ESGO eAcademy, Paolo Bruzzi, 150265

Vulvar Cancer: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Fabio Landoni, 150264

Endometrial Cancer: What Do We Know? What Don't We Know ? What Should Be Investigated?

ESGO eAcademy, Eric Pujade-Lauraine, 150263

Uterine Sarcoma: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Andres Poveda, 150262

Cervical Cancer: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Christian Marth, 150261

Welcome & Introduction

ESGO eAcademy, Nicoletta Colombo, 150269

New Classification of Uterine Sarcoma

ESGO eAcademy, Sabrina Croce, 147380

Gastric-type Mucinous Cervical Adenocarcinoma

ESGO eAcademy, Mojgan Devouassoux, 148332

Vulvovaginal Glandular Neoplasia

ESGO eAcademy, Mojgan Devouassoux, 148333

Pathology of Clear Cell Ovarian Tumors

ESGO eAcademy, Ester Oliva, 147379

New Classification and Molecular of Endometrial Cancers

ESGO eAcademy, Sigurd Lax, 147381

Pathologic Characteristics of Mucinous Tumors (Borderline and Invasive: Infltrative/expansile Subtypes)

ESGO eAcademy, Sigurd Lax, 147383

Pathological and Molecular Classification of Epithelial Ovarian Cancer

ESGO eAcademy, Sigurd Lax, 147382

Restoring the Function of Mutated P53 - a Major Contribution to Carcinogenesis

ESGO eAcademy, John A Green, 147116

Genetic Testing in Ovarian Cancer Patients: How Far Should We Go

ESGO eAcademy, Charlie Gourley, 147115

Adjuvant Therapeutic Approaches by Histological Subtype with Implications for Treatment

ESGO eAcademy, Jonathan Ledermann, 147114

Prophylactic Surgery in High Risk Population

ESGO eAcademy, Christina Fotopoulou, 147112

Laser Skinning Vulvectomy

ESGO eAcademy, Michael G. Halaska, 147110

LEEP/LLETZ and Needle Conization

ESGO eAcademy, Ilker Selcuk, 147109

Cold Knife Conization and Sturmdorf Technique

ESGO eAcademy, Ignacio Zapardiel, 147108

Simple Solutions for Developing Countries for Breast Cancer Screening

ESGO eAcademy, Murat Gultekin, 147106

Current Situation of Breast Cancer Screening Startegies in Europe and Around the World

ESGO eAcademy, Larry von Karsa, 147105

Evaluation of Mammography for the Detection of Breast Cancer in Screening Programs

ESGO eAcademy, Peter Dean, 147104

Molecular Cancer Genetics

ESGO eAcademy, Henrica Maria Johanna Werner, 147103

Endometrial Cancers Prevention and Screening Methods

ESGO eAcademy, Thierry A.M. Van Den Bosch, 147102

Chemoprevention of Endometrial Cancers

ESGO eAcademy, Pauline Wimberger, 147100

Obesity and Gynaecological Cancers

ESGO eAcademy, Maria Kyrgiou, 147099

Follow-up and Treatment of Recurrences

ESGO eAcademy, Vesna Kesic, 147098

Should CIN2 Lesions Be Treated and When?

ESGO eAcademy, Maria Kyrgiou, 147097

Screening after Vaccination

ESGO eAcademy, Jack Cuzick, 147096

Novel Molecular Techniques in Screening & Diagnosis & Prediction

ESGO eAcademy, Jack Cuzick, 147094

Cytology vs. HPV for Primary Screening

ESGO eAcademy, Marc Arbyn, 147093

Cervical Cancer Screening in Low and High Resource Settings

ESGO eAcademy, Partha Basu, 147092

HPV Prophylactic Vaccines: Lessons Learned from 10 Years Experiences

ESGO eAcademy, Xavier Bosch, 147090

HPV Related Cancers: the Comparative Figures in the World

ESGO eAcademy, Partha Basu, 147089

The Human Papillomavirus Types and the Type-specific Risks for Disease

ESGO eAcademy, Joakim Dillner, 147088

Quality Assurance for the Surgical Management of Ovarian Cancer and ESGO Certification

ESGO eAcademy, Denis Querleu, 139309

Goals and Limits of Surgery in Advanced Ovarian Cancer

ESGO eAcademy, Luis M. Chiva, 139308

Combining a Surgical and Treatment Question in the Same Trial. Is It Feasible?

ESGO eAcademy, Mansoor Raza Mirza, 135850

Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: a Unique Opportunity for Traslational Research

ESGO eAcademy, sandro pignata, 135849

Algorithm To Select Patients for Primary Cytoreductive Surgery versus Neoadjuvant Chemotherapy

ESGO eAcademy, Christian Marth, 135848

Quality Assessment in Ovarian Cancer Surgery

ESGO eAcademy, Andreas Du Bois, 135847

Immune Check Points

ESGO eAcademy, Iain McNeish, 135846

Cell Cycle Check Points

ESGO eAcademy, Cristiana Sessa, 135845

P53

ESGO eAcademy, Nicole Concin, 135844

Defective DNA Repair as a Target in Ovarian Cancer

ESGO eAcademy, Ignance Vergote, 135843

Results from Group C: Lights and Shadows on Rare Ovarian Tumors

ESGO eAcademy, Nicoletta Colombo, 135842

Results from Group D: Lights and Shadows on Stratification Factors, Control Groups and Endpoints in Recurrent Disease

ESGO eAcademy, Eric Pujade-Lauraine, 135841

Results from Group B: Lights and Shadows on Control Groups and Endpoints in Front Line

ESGO eAcademy, Nicoletta Colombo, 135840

How To Organize a Consensus Conference: Methodology and SOPs

ESGO eAcademy, Andreas Du Bois, 135838

Results from Group A: Lights and Shadows on Stratification Factors (Clinical, Pathologic and Molecular) in Front Line

ESGO eAcademy, Andrés Poveda, 135839

Intra-cavitary and Interstitial Image Guided Brachytherapy in Locally Advanced Cervical Cancer

ESGO eAcademy, Christine Haie-Meder, 131621

Particularity of the Surgical Management of Mucinous Ovarian Tumors

ESGO eAcademy, Philippe Morice, 131619

Molecular Characteristics, Trials and Targeted Therapies in Clear Cell Ovarian Tumors

ESGO eAcademy, Alexandra Leary, 131618

Molecular Characteristics, Trials and Targeted Therapies in Mucinous Ovarian Tumors

ESGO eAcademy, Alexandra Leary, 131617

Particularities of Anesthesiologic Management of Debulking Surgery in Ovarian Cancer

ESGO eAcademy, Stephanie Suria, 131616

ESGO – EBCOG - Teach the Visitors Modules - Training Course for Hospital Visitors

ESGO eAcademy, Prof. René H.M. Verheijen and Michael J. Halaska, 128206

ESGO - Fellow Training

ESGO eAcademy, Rene H.M. Verheijen, 128205

Treatment of NE Cancers of Genital Tract

ESGO eAcademy, Nicholas Reed, 117678

Pathology of Neuroendocrine Tumours of Genital Tract

ESGO eAcademy, Sigurd Lax, 117677

Treatment of Sex Cord and Stromal Tumours

ESGO eAcademy, Isabelle Ray-Coquard, 117676

Pathology of Sex Cord and Stromal Tumours

ESGO eAcademy, Mojgan Devouassoux, 117675

Panel Discussion to Video Series on Surgical Treatment of Early Stage Cervical Cancer

ESGO eAcademy, Speakers Session, 117660

Place of Interventional Radiology in the Management of Immediate and Late Postoperative Complications

ESGO eAcademy, Frederic Deschamps, 117672

Radio-Induced Chronic Enteritis in Uterine Cancer: How To Prevent, How To Manage?

ESGO eAcademy, Jervoise Andreyev, 117671

QOL after Radical Surgery in Cervical/Endometrial Cancer

ESGO eAcademy, Elena Ulrikh, 117670

New Nuclear Medicine Approaches-Beyond FDG

ESGO eAcademy, Jean-Noël Talbot, 117648

Image Guided Adaptive Brachytherapy for Vaginal Cancer, Vaginal Recurrences and Endometrial Cancer

ESGO eAcademy, Remi Nout, 117651

Imaging Lymph Nodes and Recurrent/Relapsed Disease

ESGO eAcademy, Andrea Rockall, 117647

Image Guided Adaptive Brachytherapy for Cervical Cancer Combined with External Beam Radiochemotherapy

ESGO eAcademy, Richard Pötter, 117650

Imaging the Primary Site (Cervix, Endometrium, Ovaries, Peritoneum)

ESGO eAcademy, Nandita de SOUZA, 117646

Advances in Pelvic External Beam Image Guided Adaptive Radiochemotherapy

ESGO eAcademy, Richard Pötter, 117937

Faults in Colposcopy

ESGO eAcademy, Vesna Kesic, 117645

Current Role of Colposcopy in Diagnostics of Low Genital Tract Pathology

ESGO eAcademy, Jiri Slama, 117644

The Future Role of Biological Markers in the Surgical Treatment Planning

ESGO eAcademy, MICHAEL BIRRER, 117640

Immunotheraoy of Ovarian Cancer

ESGO eAcademy, Eric Pujade-Lauraine, 117643

How To Select the Patients in an Appropriated and Dedicated Surgical Center?

ESGO eAcademy, Giovanni Aletti, 117639

Therapeutic Vaccines for Cervical Cancer

ESGO eAcademy, Cornelis Melief, 117642

Any Borders in Cytoreductive Surgery? Which Are?

ESGO eAcademy, Christina Fotopoulou, 117638

Ovarian Cancer: Ovarian Management in Young Patients with BRCA-Mutations

ESGO eAcademy, Catherine Uzan, 117637

Lymphadenectomy

ESGO eAcademy, Christhardt Koehler, 117633

Endometrial Cancer: Clinical Recommendation for Conservative Treatment in Low Risk Disease

ESGO eAcademy, Alexander Rodolakis, 117636

Radical Hysterectomy (Cons)

ESGO eAcademy, Christophe Pomel, 117632

Breast Cancer: Ovarian Damage by Systemic Treatment and the Role of Protection by GNRH Analogues

ESGO eAcademy, Dominik Denschlag, 117635

Lymphadenectomy

ESGO eAcademy, Henrik Falconer, 117631

Robot vs Laparoscopy: Chair

ESGO eAcademy, K. Rainer Kimmig, 117628

Radical Hysterectomy (Pros)

ESGO eAcademy, Angelo Maggioni, 117630

Personalised Risk Prediction and Prevention - the Role of Social Media Networks

ESGO eAcademy, Caroline Presho, 117623

Recurrent Ovarian Cancer and Hipec

ESGO eAcademy, Philipp Harter, 117627

Personalised Treatment in Women´s Cancer

ESGO eAcademy, Helga B Salvesen, 117622

Primary Ovarian Cancer

ESGO eAcademy, Sven Mahner, 117626

An Update on Current Strategies For Women´s Cancer Prevention

ESGO eAcademy, Jack Cuzick, 117621

Surgical Trials (EBM): Endometrial Cancer

ESGO eAcademy, Stefano Greggi, 117625

Cervical and Vulvar Cancer

ESGO eAcademy, Marie Plante, 117624

MIS, Next Step: Image Guided Surgery

ESGO eAcademy, Jacques Marescaux, 117619

Radiation Therapy and Anti-Hpv Treatment

ESGO eAcademy, Eric Deutsch, 117618

Stage IIB-III: How Can We Improve Outcomes for Advanced Cervical Cancer?

ESGO eAcademy, Gillian Thomas, 117613

Dose Adaptation for Pelvic / Para-Aortic Nodes

ESGO eAcademy, Ina Jϋrgenliemk-Schulz, 117617

Stage IB2: Radical Hysterectomy or Chemoradiation?

ESGO eAcademy, Denis Querleu, 117612

Is Radical Hysterectomy Necessary in Low Volume Disease?

ESGO eAcademy, Pedro Ramirez, 117611

Brachytherapy Data: Which Doses for Which Tumours?

ESGO eAcademy, Christine Haie-Meder, 117918

Systemic Treatment, Including Adjuvant

ESGO eAcademy, Patricia Pautier, 117610

Surgery

ESGO eAcademy, Frederic Amant, 117609

Pathology

ESGO eAcademy, Catherine Genestie, 117608

Systemic Treatment, Including Adjuvant

ESGO eAcademy, Patricia Pautier, 117607

Surgery

ESGO eAcademy, Frederic Amant, 117606

Pathology

ESGO eAcademy, Catherine Genestie, 117605

Complex Vaccination Strategies in Cervical Cancers

ESGO eAcademy, Suzy Scholl, 117600

Clinical Applications of Molecular and Genetic Predictive Factors in Endometrial Cancer

ESGO eAcademy, MICHAEL BIRRER, 117595

Controversies in the Management of Intermediate Risk Endometrial Cancer

ESGO eAcademy, Mansoor Raza Mirza, 117594

Overview on HPV Trials and an Update on Recent Advances on HPV Research

ESGO eAcademy, Gemma G. Kenter, 117598

Role of Radiation Therapy in Intermediate Risk Group

ESGO eAcademy, Carien Creutzberg, 117593

Immunotherapy Approaches in Ovarian Cancer

ESGO eAcademy, Petronella B. Ottevanger, 117597

Surgical Staging and Potential Role of Sentinel Node Biopsy

ESGO eAcademy, Sean C. Dowdy, 117592

Risk Communication in Oncogenetics

ESGO eAcademy, Jan Oosterwijk, 117590

Advanced and Recurrent Disease

ESGO eAcademy, Jonathan Ledermann, 117587

Adjuvant Treatment

ESGO eAcademy, Remi Nout, 117586

Implementation of BRCA Sequencing in an Oncology Clinic

ESGO eAcademy, Susana Banerjee, 117589

Surgery

ESGO eAcademy, Christian Marth, 117585

Prevention and Screening

ESGO eAcademy, Frederic Amant, 117584

Molecular Testing in Ovarian Cancer; How Far Should We Go?

ESGO eAcademy, Charlie Gourley, 117588

Evaluation of Self-Collected Vaginal Samples and Urine an a Test-of-Cure Setting

ESGO eAcademy, Sonia Andersson, 117578

Tissue and Imaging Biomarkers for Hypoxia Predicts Poor Outcome in Endometrial Cancer

ESGO eAcademy, Anna Berg, 117577

Surgical Management of Extrapelvic Recurrences

ESGO eAcademy, Neville F. Hacker, 117582

Systematic BRCA1/2 Genetic Testing in Unselected Epithelial Ovarian Cancer- Results from the Gteoc Study

ESGO eAcademy, Robin Crawford, 117576

Reconstructive Procedures After Pelvic Exenteration

ESGO eAcademy, Luis M. Chiva, 117581

LAPAROSCOPY TO PREDICT THE RESULT OF PRIMARY CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN CANCER (LAPOVCA): A MULTICENTRE RANDOMISED CONTROLLED TRIAL.

ESGO eAcademy, Marrije Buist, 117575

Update on Pelvic Exenteration in 2015

ESGO eAcademy, David Cibula, 117580

Activation of TGF-Beta Pathway Through Mir-181a and Psmad-2 Overexpression Drives Resistance To Neoadjuvant Chemotherapy in High Grade Serous Advanced Ovarian Cancer

ESGO eAcademy, Marco Petrillo, 117574

Engot-OV-6/Trinova-2: Randomised, Double-Blind, Phase 3 Study of Pegylated Liposomal Doxorubicin Plus Trebananib or Placebo in Women with Recurrent Partially Platinum-Sensitive or Resistant Ovarian Cancer

ESGO eAcademy, Christian Marth, 117573

Palliative and Non-Palliative Surgical Interventions in Relapsed Ovarian Cancer

ESGO eAcademy, Jalid Sehouli, 117579

Targeting HSP-90 in Gynaecological Cancer

ESGO eAcademy, Nicole Concin, 117567

New Antiangiogenic and Vascular Disrupting Agents and Their Combinations

ESGO eAcademy, Antonio Casado, 117566

RAS RAF MEK ERK Pathway

ESGO eAcademy, Cristiana Sessa, 117565

Potential Interest and Place of Uterine Transplantation in Gynaecologic Oncology

ESGO eAcademy, Yves Aubard, 117563

Oncologic Risk in Immuno-Suppressed Patients for Transplantation

ESGO eAcademy, Josep M. Grinyó, 117562

First Results of Uterus Transplantation in Human

ESGO eAcademy, Pernilla Dahm-Kähler, 117561

How To Manage BRCA Mutated Patients?

ESGO eAcademy, Eric Pujade-Lauraine, 117551

Surgical and Systemic Treatment of Recurrences

ESGO eAcademy, Andreas Du Bois, 117550

Putting It All Together: the Impact of a Comprehensive, Standardised Enhanced Recovery Programme

ESGO eAcademy, Sean C. Dowdy, 117554

Systemic Therapy: from Chemotherapy to Targeted Therapy in Front Line and at Recurrence

ESGO eAcademy, Nicoletta Colombo, 117549

The Role of Nutrition in Perioperative Recovery

ESGO eAcademy, Federico Bozzetti, 117553

Surgical Treatment of Primary and Recurrent Ovarian Cancer

ESGO eAcademy, Émile Darai, 117548

How Anesthesia Can Improve Postoperative Recovery

ESGO eAcademy, Stephanie Suria, 117552

Horizon Scanning-Emerging Strategies for Recurrent Disease

ESGO eAcademy, Cristiana Sessa, 117546

Advanced Stage with Emphasis on Management of Patients with Positive Paraaortic Nodes

ESGO eAcademy, Christine Haie-Meder, 117537

Current Options for Relapsed Cervical Cancer

ESGO eAcademy, Jonathan Ledermann, 117545

Surgical Management of Early Disease

ESGO eAcademy, Nicoletta Colombo, 117544

Rationale and Evidence for Tailored Approach to Early Stage Disease

ESGO eAcademy, David Cibula, 117536

Managing Early Relapse- Experimental Therapeutics

ESGO eAcademy, Cristiana Sessa, 117543

Current Choices for First Line Therapy

ESGO eAcademy, Jonathan Ledermann, 117542

Surgery or Neoadjuvant Chemotherapy

ESGO eAcademy, Nicoletta Colombo, 117541

Update on Fertility Sparing Treatment

ESGO eAcademy, Nadeem Abu Rustum, 117535

Importance of Multidisciplinary Management of Gynaecological Cancers

ESGO eAcademy, Jonathan Ledermann, 117540

Clinical Trial for Rare Tumours: List of Ongoing and Future Clinical Trials in EU and Unanswered Questions

ESGO eAcademy, Isabelle Ray-Coquard, 117530

Peritoneal Mesothelioma: Who Benefits from Radical Surgery?

ESGO eAcademy, Marcello Guaglio, 117533

Current Management of Appendiceal Neoplasia and Pseudomyxomes Peritonei

ESGO eAcademy, Sarah O'Dwyer, 117532

Organisation of Health Care Providers for the Treatment of Rare Peritoneal Malignancies: the French Way (Renape)

ESGO eAcademy, Olivier Glehen, 117531

Stage IV Ovarian Cancer: Prognosis of Patients with Exclusively Abdominal Wall Metastasis

ESGO eAcademy, Florian Heitz, 117712

The Impact of Lymph Node Dissection and Adjuvant Chemotherapy on Survival in Early-Stage Ovarian Cancer. Data of 3658 Patients

ESGO eAcademy, Marjolein Kleppe, 117525

Outcome of 129 Children After Antenatal Exposure to Cancer Treatment: Results of a Case-Control Study from the International Network on Cancer, Infertility and Pregnancy Registry

ESGO eAcademy, Frederic Amant, 117524

Prospective Evaluation of Lymphocele Incidence in Patients After Pelvic and Paraaortic Lymphadenectomy and Analysis of Risk Factors for Their Development

ESGO eAcademy, Michal Zikan, 117523

CA125 GC1G Criteria: Still Valid in the Era of Targeted and Immunologic Therapies

ESGO eAcademy, Bradley Monk, 116825

Response and Progression Criteria in Trials with Targeted Therapy. Recist and Variation

ESGO eAcademy, Cristiana Sessa, 116824

Response and Progression Criteria in Trials with Cytotoxic Agents: Recist and Variation

ESGO eAcademy, Andrés Poveda, 116822

Available Drugs Targeting the Known Altered Pathways in Ovarian Cancer

ESGO eAcademy, Cristiana Sessa, 116821

Potential Actionable Target Pathways in the Different Types of Ovarian Cancer

ESGO eAcademy, Iain McNeish, 116820

How to Measure the Benefit of Chemotherapy-Free Interval in a Trial with Maintenance Targeted Therapy? The Importance Combined Endpoints

ESGO eAcademy, Bradley Monk, 116819

How to Define Platinum-Resistance or Sensitivity after Several Lines of Treatment?

ESGO eAcademy, Jonathan Ledermann, 116818

Debate: Platinum-Free Interval is Still a Valid Tool in Guiding Treatment Decision - CON

ESGO eAcademy, sandro pignata, 116817

Debate: Platinum-Free Interval is Still a Valid Tool in Guiding Treatment Decision - PRO

ESGO eAcademy, Mansoor Raza Mirza, 116816

Welcome and Introduction: The Changing Landscape of Clinical Trials in the Era of Targeted and Immunologic Therapies: Different Patient Selection, New Endpoints, New Responsible Criteria

ESGO eAcademy, Nicoletta Colombo, 116815

Possible role of robotics in ERAS

ESGO eAcademy, Eric Lambaudie, 105096

What is the place of sentinel procedures in gynecologic Oncology?

ESGO eAcademy, Rene H.M. Verheijen, 105095

Robotic single-site pelvic lymphadenectomy

ESGO eAcademy, Liliana Mereu, 106938

Endoscopic staging in early stage ovarian cancer

ESGO eAcademy, Eric Lambaudie, 106937

Key Lecture: Critical considerations on Robotic Surgery for the treatment of Endometrial Cancer

ESGO eAcademy, Angelo Maggioni, 105137

What progress is made and expected the coming decade in endoscopic (non-robotic) gynaecological surgery ?

ESGO eAcademy, Farr Nezhat, 105090

Single site robotic hysterectomy

ESGO eAcademy, Fatih Sendag, 105088

Compartment imaging with fluorescence

ESGO eAcademy, K. Rainer Kimmig, 105087

New robots and implementation

ESGO eAcademy, Rene H.M. Verheijen, 105086

Paraaortic lymphadenectomy and surgical approach

ESGO eAcademy, Fabrice Narducci, 105085

Robotic radical trachelectomy

ESGO eAcademy, M. Faruk Kose, 105084

Robotic-assisted radical hysterectomy: oncology outcomes

ESGO eAcademy, Vanna Zanagnolo, 105083

Key lecture: Radical hysterectomy: Overview of the different techniques of parametrial dissection

ESGO eAcademy, K. Rainer Kimmig, 105082

European Reference Network

ESGO eAcademy, Francois Golfier, 99309

Future Perspectives in Gestational Trophoblastic Disease

ESGO eAcademy, Leon Massuger, 99308

PSTT/ETT

ESGO eAcademy, Barry Hancock, 99307

When EMACO Does Not Cure

ESGO eAcademy, Michael Seckl, 99305

Case Report Hi Dose

ESGO eAcademy, Kirsty Balachandran, 99304

Treatment of High Risk Gestational Trophoblastic Disease

ESGO eAcademy, John Tidy, 99303

Case: High Risk Gestational Trophoblastic Disease

ESGO eAcademy, Mireille Vree, 99302

Treatment of Low Risk Gestational Trophoblastic Disease

ESGO eAcademy, John Coulter, 99301

Case: MTX Resistance

ESGO eAcademy, Sam Schoenmakers, 99300

Histologic and Immunohistochemic Features of Trophoblastic Disease

ESGO eAcademy, Sophie Patrier, 99299

Case Report Pathology

ESGO eAcademy, Gwendoline Side-Pfennig, 99298

HCG in Gestational Trophoblastic Disease

ESGO eAcademy, Teun van Herwaarden, 99295

Case: Clinical Consequences of Different hCG Assays

ESGO eAcademy, Yalck Eysbouts, 99294

History of Gestational Trophoblastic Disease

ESGO eAcademy, Rene H.M. Verheijen, 99293

Immunotherapy Represents the Future for Ovarian Cancer

ESGO eAcademy, Bradley Monk, 96876

Immunotherapy Has Never Worked and Will Never Work in Ovarian Cancer

ESGO eAcademy, Eric Pujade-Lauraine, 96875

How To Negotiate Support with Pharma Companies for Sponsored Trials

ESGO eAcademy, Andreas Du Bois, 96873

How To Write a Grant for Academic Trials (Investigator-Initiated)

ESGO eAcademy, sandro pignata, 96872

The Hurdles of Conducting Trials across Different Countries: Focus on EU Regulations and Differences Which May Constitute Barriers to Run an ENGOT Trial

ESGO eAcademy, Jacobus Pfisterer, 96871

The Challenge of Initiating a National Cooperative Trial Group: Tricks and Tips

ESGO eAcademy, Mansoor Raza Mirza, 96870

Outside EU Regulations: Activating a Study in Switzerland

ESGO eAcademy, Cristiana Sessa, 96983

Reversing Mutated p53 to Wild Type

ESGO eAcademy, Sevilay Altintas, 63068

Inhibiting the Gain-of-Function of Mutated p53

ESGO eAcademy, Nicole Concin, 63067

Why Signatures Miss the Goal in Ovarian Cancer

ESGO eAcademy, MICHAEL BIRRER, 63066

Why Signatures Are the Best Way to Identify Subgroups in Ovarian Cancer

ESGO eAcademy, Charlie Gourley, 63065

The Tricky Decision to Allow Cross-Over or Not in a Trial

ESGO eAcademy, Bradley J. Monk, 63064

Funding Options, Legal Aspect and Insurance Hurdles, How To Select Centers for Surgical Trials?

ESGO eAcademy, Jacobus Pfisterer, 63060

What Are the Endpoints and Do We Have the Right Questionnaires for QOL? What Are the Open Questions in Relapse Ovarian Cancer?

ESGO eAcademy, Philipp Harter, 63061

Robotic debulking surgery

ESGO eAcademy, Javier Magrina, 63093

EU reimbursement update and the role of medical expertise in Driving Dr.G change

ESGO eAcademy, Susanne Habetha, 63134

Chance of cost reduction and increase of efficiency in robotic surgery

ESGO eAcademy, Petur Reynisson, 63133

Cost analysis in endometrial cancer patients

ESGO eAcademy, Frederic Goffin, 63132

Cost evaluation (French analysis)

ESGO eAcademy, Eric Lambaudie, 63131

How to implement a registry?

ESGO eAcademy, Eric Lambaudie, 63092

The 'Art of Docking': Key for successful robotic surgery

ESGO eAcademy, Henrik Falconer, 63130

Robotic skills assessment: to score or not score ?

ESGO eAcademy, Henk Schreuder, 63088

Compartment visualization in embryologically defined surgery

ESGO eAcademy, Martin Heubner, 63129

Education in robotics: The U.S. experience

ESGO eAcademy, Gokhan S. Kilic, 63089

Applicability and feasibility of laparoscopic surgery of uterine cancer in patients with BMI under 30. Evaluation of a policy in favor of minimal invasive surgery in a single center

ESGO eAcademy, Denis Querleu, 63126

Perioperative morbidity and outcome analysis of robotically assisted laparoscopic radical hysterectomy

ESGO eAcademy, Fabrice Narducci, 63125

Robotic surgery and technique of radical hysterectomy in cervical and endometrial cancer

ESGO eAcademy, Angelo Maggioni, 63124

Evidence for adequate quality in radical hysterectomy by endoscopy

ESGO eAcademy, Roberto Tozzi, 63123

Present and future development of robotic surgery in gynecology: Visions, expectations and demands

ESGO eAcademy, Ignance Vergote, 63083

RoundTable (Questions&Answers) of State of the Art Conference

ESGO eAcademy, Session Speakers, 62459

Patient´s expectations and perspectives about cancer care in ovarian cancer

ESGO eAcademy, Elena Ioana Braicu, 62458

Follow up of advanced stage invasive ovarian cancers

ESGO eAcademy, Gordon J.S. Rustin, 62457

Follow up of early stage invasive ovarian cancer, fertility sparing treatment

ESGO eAcademy, Rene H.M. Verheijen, 62456

Non epithelial ovarian tumours

ESGO eAcademy, Nicoletta Colombo, 62455

Borderline ovarian tumor follow up

ESGO eAcademy, Philippe Morice, 62454

Familial risk and its management

ESGO eAcademy, Usha Menon, 62453

Imaging strategies for follow up

ESGO eAcademy, Nandita de SOUZA, 62451

Imaging strategies for follow up

ESGO eAcademy, Manuela LUDOVISI, 62452

The Role of the Pathologist in Planning Follow up

ESGO eAcademy, Silvestro CARINELLI, 62450

The Role of Biomarkers in the Follow up in Ovarian Cancer

ESGO eAcademy, Massimo GION, 62449

Take home message of State of the Art Conference

ESGO eAcademy, K. Rainer Kimmig, 62446

RoundTable (Questions&Answers) of State of the Art Conference

ESGO eAcademy, Panel, 62444

Follow up of special histotypes including sarcomas

ESGO eAcademy, Nicholas Reed, 62443

Follow up after the treatment of endometrial cancer

ESGO eAcademy, ENRICO SARTORI, 62442

Endometrial cancer: Familial risk and its management

ESGO eAcademy, Usha Menon, 62441

Imaging strategies in the follow-up of endometrial cancer

ESGO eAcademy, Nandita de SOUZA, 62439

Imaging strategies for follow up

ESGO eAcademy, Manuela LUDOVISI, 62440

The Role of the Pathologist in Planning Follow up

ESGO eAcademy, Sigurd Lax, 62438

Take home message of State of the Art Conference

ESGO eAcademy, Tiziano Maggino, 62434

Take home message of State of the Art Conference

ESGO eAcademy, David Cibula, 62435

RoundTable (Questions&Answers)of State of the Art Conference

ESGO eAcademy, Session Speakers, 62433

Follow up after integrated therapy

ESGO eAcademy, Nicholas Reed, 62432

Follow up after surgical treatment

ESGO eAcademy, Tiziano Maggino, 62431

Imaging strategies for follow up

ESGO eAcademy, Nandita de SOUZA, 62429

Imaging Strategies for follow up

ESGO eAcademy, Manuela LUDOVISI, 62920

The Role of the Pathologist in Planning Follow up in Endometrial Cancer

ESGO eAcademy, Sigurd Lax, 62428

The Obstetrics Management after fertility sparing Treatment

ESGO eAcademy, Tullia TODROS, 62427

Follow up after Fertility Sparing Treatment

ESGO eAcademy, Fabio Landoni, 62426

Follow up after the treatment of cervical pre-cancer and microinvasive cancer

ESGO eAcademy, Vesna Kesic, 62425

The cost of follow up: looking for efficacy and effectiveness

ESGO eAcademy, Giovannino CICCONE, 62419

The psychological impact of the follow up procedures

ESGO eAcademy, Eva Greimel, 62418

Risk of secondary cancer after treatment of gynaecological cancer

ESGO eAcademy, David Cibula, 62417

The role of the imaging (CT-RMI-PET/CT) in the follow up

ESGO eAcademy, Nandita de SOUZA, 62416

The role of ultrasound procedures in the follow up

ESGO eAcademy, Manuela LUDOVISI, 62415